Background The amount of resources, particularly prepaid resources, available for health can affect access to health care and health outcomes. Although health spending tends to increase with economic development, tremendous variation exists among health financing systems. Estimates of future spending can be beneficial for policy makers and planners, and can identify financing gaps. In this study, we estimate future gross domestic product (GDP), all-sector government spending, and health spending disaggregated by source, and we compare expected future spending to potential future spending.
Introduction
Anticipation of future health spending and the source of that funding is vital for effective health policy. With reliable spending forecasts, decision makers can adjust long-term planning and processes. Investments can be made strategically to counter shortfalls or enhance growth in coming years. Because dependence on out-of-pocket health payments has been shown to reduce access to health services and increase medical impoverishment in some settings, understanding how funds will be collected, and if they will be prepaid and pooled across groups, is also of crucial importance. [1] [2] [3] [4] [5] [6] [7] [8] The source of health funding often dictates the types of services and supplies procured and how efficiently those resources are deployed. [9] [10] [11] [12] [13] Without careful planning, limited resources for health can translate into insufficient access to health services and an over-reliance on out-of-pocket payments. 14 The health financing transition describes how health financing changes, on average, as countries develop economically: per capita health spending increases and out-of-pocket expenses comprise a smaller share of total health expenditure than previously. 15 However, tremendous variation in health financing systems and the associated levels of financing underpins these trends. In 2014, spending per capita in low-income countries varied from US$33 to $347, and per capita spending in high-income countries varied from $853 to $9237. The health financing transition is not guaranteed to continue as new countries progress through various stages of development. Prospective health spending estimates show what past trends and relationships suggest regarding future spending and sources of those funds.
Development assistance for health is no longer an expanding resource for developing country health budgets. Tepid growth in this area since 2010 suggests that external funding will not grow at the rate seen earlier in the millennium. This prediction intensifies the need to increase domestic spending on health in some of the poorest countries. Fiscal space analyses have been done in a number of these countries to help prepare for the slowing down of development assistance for health growth. 16, 17 However, few studies have comprehensively and empirically assessed what forecasts of future income mean for government health spending and other sources of health financing. [18] [19] [20] [21] Among the forecasting studies that do exist, [22] [23] [24] few assess mechanisms that alter financing trajectories, such as future macroeconomic scenarios, changes in country prioritisation, technological advancements, and other developments.
The objective of this study is to empirically assess how existing health financing trends and relationships could be shifted and, more generally, how the need for health resources can be met in an ever-evolving global economy. Using novel methods, we estimated future gross domestic product (GDP), all-sector (also known as general) government spending, and health spending through to year 2040. We then assessed alternative scenarios in health financing, highlighting how fiscal policy changes (in government spending levels and the allocation of those resources) could affect future health spending. Together, economic forecast indicators and health spending estimates show expected and potential health expenditure, which are essential inputs to decision making as the global context becomes increasingly uncertain.
Methods

Overview
We estimated national GDP, all-sector government spending, and health spending for each year through
Research in context
Evidence before this study Forecasts of total health spending, and health spending disaggregated by source into government spending, out of pocket, prepaid private, and development assistance for health are crucial inputs into health-system planning. Understanding of the opportunity to alter these probable trajectories through plausible increases in the share of gross domestic product (GDP) spent by government or the share of government expenditure spent on health to expand fiscal space for health has also become an important dimension of health policy in the era of Sustainable Development Goals.
Country-specific forecasts have been developed for a few countries. The Organisation for Economic Co-operation and Development periodically produces forecasts to 2060 for its member states and the Brazil, Russia, India, China, and South Africa. The only comprehensive set of health expenditure forecasts covering a comprehensive set of countries has been produced by Dieleman and colleagues in 2016 .
Added value of this study
This study advances our previous assessment of future health spending in three ways. First, a key driver of future health spending in total and by source is economic development, often measured by GDP per capita. Given that there is no regularly updated set of GDP forecasts that extends to 2040 and covers all countries with similar methods, we developed GDP forecasts. To improve on previous methods used to forecast GDP and follow good forecast practice applied in other fields, we switched to forecasting GDP using an ensemble of models. We developed 1664 models and selected the 136 that met predetermined inclusion criteria and had the best out-of-sample performance. These revised GDP forecasts are more optimistic than previous estimates for Luxembourg, Qatar, and especially China. Second, we modelled the share of GDP spent by government to derive all-sector government spending estimates. These forecasts allowed us to estimate government health spending as a share of all-sector government spending. These techniques better reflect the reality that health spending by government is constrained by the size of government. This two-stage modelling of government spending captures the direct competition for scarce government resources between sectors. Third, we studied the potential of low-income and middle-income countries to increase the amount spent on health by increasing the share of GDP spent by the government, increasing the share of government budgets spent on health, or both. This exploration of the fiscal space to increase health spending was not previously completed, and was done empirically by fitting a frontier to the observed spending patterns at each level of development. This study is the first, to our knowledge, to provide a prospective empirical assessment of the potential to increase health spending in all low-income and middle-income countries.
to 2040 for 184 countries based on past trends of the relationships between demographic and financial data over time. Future health spending was estimated by source: government, out-of-pocket, and prepaid private health spending as well as developmental assistance for health received. These four source-specific spending estimates were aggregated to form total national health spending. All projections were similar and consistent, and were based on ensemble models. Ensemble models are a standard in some areas of forecasting and rely on the estimation of many individual models and pooling the results to form a single estimate with uncertainty intervals [UIs] . These types of models have been shown to be more accurate than traditional single specification models in some circumstances. [25] [26] [27] Additionally, our models incorporated codependencies, such that macroeconomic variables and each of the health spending variables affected each other. These methods build on previously published research with substantive improvements and are described more thoroughly in the appendix. 28 Figure 1 outlines the processes used to estimate future GDP, all-sector government spending, and health spending by source.
Data
We extracted health spending data for 184 countries spanning 1995 to 2014 from the Institute for Health Metrics and Evaluation's Financing Global Health 2016 database. 14, 29 These data track government health spending from domestic sources, including general budget support and social health insurance; prepaid private health spending, which includes private insurance and non-governmental organisation spending; out-of-pocket health spending, which includes all spending at point-of-service and copayments; and developmental assistance for health. The data were collated and missing values (1·7% of the government spending, 14·8% of prepaid private spending, and 1·7% of out-of-pocket health spending) were imputed with multiple imputation methods from Amelia II: a program for missing data in R. 30 The final series of data were mutually exclusive and exhaustive estimates of total health spending in each country.
GDP and all-sector government spending data spanning 1980 to 2015 were based on data collected from the International Monetary Fund, the UN, the Maddison Project, and Penn World Tables database. [31] [32] [33] [34] [35] These data were combined with use of regression methods and previously developed for producing a complete GDP time series. 36 All health spending, GDP, and all-sector government spending estimates from this database were reported in inflation-adjusted 2015 purchasing power parity adjusted US$.
Estimating future GDP
We used an ensemble model that capitalised on past trends and relationships to predict GDP for 184 countries from 2016 through 2040. 28 These models are based on data from 1980 to 2015. Altogether, 1664 models were considered to estimate the future growth rate of GDP, measured as the difference in natural log-transformed GDP. The independent variables considered were total population, share of the population younger than 20 years 
Additional covariates
• All models are estimated using first-order differences and country-specific random intercepts • All ensemble models considered up to three degrees of autoagressive terms • GDP per capita ensemble models considered a convergence term, up to three degrees of autocorrelation, and four potential weighting schemes across recent years and observations • All-sector government spending ensemble models considered up to one degree of autocorrelation The process diagram indicates the data used by each ensemble for estimating future GDP, all-sector government spending, government health spending, prepaid private health spending, out-of-pocket health spending, or DAH.
The number of models considered is the universe of specific model specifications considered for that ensemble model. Each individual model was tested against three exclusion criteria. The number of models that passed each criterion is also indicated. DAH=development assistance for health. GDP=gross domestic product.
of age, total fertility rate, and a convergence term, which is the 1 year lag of the non-differenced dependent variable.
The 1664 models included all combinations of independent variables. More specific information about the universe of models, precise model specifications, and estimated coefficients are included in the appendix. All models were assessed against three exclusion criteria. First, we excluded models with any independent variable that was not statistically significant (α=0·1). Second, we excluded models that estimated a coefficient greater than zero for the convergence term. Third, we excluded models that produced predictions that fell outside the bounds of growth observed in the underlying data (1980-2015; appendix) . After implementation of these exclusion criteria, 547 models remained.
Of these 547 models, country forecasts were based on the best performing 25% of models (136 models). The best performing models were identified by the country-specific out-of-sample validation based on root-mean-squared error. To compute this, 10 years of observed data were withheld, the 547 models were rerun, and predicted values for 2006-15 were compared against actual values. The 136 models selected for each country-specific and year-specific models were rerun on the entire observed data set to maximise use of observed data.
Uncertainty was propagated in three ways. First, we used the ensemble modelling framework to incorporate model uncertainty. Second, we took 74 random draws from the estimated variance-covariance matrix of each model to create more than 10 000 draws to incorporate parameter uncertainty. (74 random draws was the smallest number of draws that could be used for each of the 136 models to ensure at least 10 000 total draws.) Lastly, we added correlated periods of growth or recession across countries to model global recessions, and also added country-specific and year-specific periods of growth and recession to model otherwise unexpected country-specific growth or recession. We report a pointestimate, and lower and upper confidence interval based on the mean, 2·5th and 97·5th percentile of the 10 064 draws.
Estimating future all-sector government spending and health spending by source All-sector government spending, out-of-pocket health spending, and prepaid private health spending were each modelled as a share of GDP with the same method used to estimate future GDP. Government health spending was modelled as a share of all-sector government spending with the same methods. For each of these models, GDP per capita (natural log-transformed) was included as a potential independent variable in the ensemble. For each of the three health spending ensembles, a 1 year lag of the other health spending variables and all-sector government spending per capita (natural log-transformed) was also included in the ensemble to ensure codependence across the health spending estimates.
We used a three-step process to estimate the amount of future development assistance for health disbursed to each low-income or middle-income country. These methods were based on previously published research. 37 First, we extracted development assistance for health provided by 24 major sources of development assistance and modelled development assistance for health provided as a share of the source's GDP to make estimates of total development assistance for health provided through 2040. These sources of development assistance for health are generally national treasuries, for example, those of the USA or UK, or major donors such as the Bill & Melinda Gates Foundation. Second, we modelled development assistance for health received, measured as a share of the total amount of development assistance for health provided to each low-income or middle-income country through 2040. Finally, we estimated the transition of countries from middle-income to high-income status on the basis of GDP per capita estimates. This transition, estimated to be when GDP per capita surpasses $18 108 per capita, marks the point at which, according to our definition of development assistance for health, a country is no longer eligible to receive development assistance for health. To estimate expected total health spending, we summed development assistance for health received and government, prepaid private, and out-ofpocket health spending.
Potential health and government health spending
To estimate potential health spending in low-income and middle-income countries, we used stochastic frontier analysis. In our analysis, this frontier represents the amount of spending generated by the countries with the most health spending given their level of economic development. In this case, the frontier represents potential spending, based on a country's GDP per capita and peers' health spending. For our frontier analyses, we assumed a half-normal distribution of residual, although the appendix shows robustness analyses exploring the effect of alternative assumptions. This analysis was completed with only low-income and middle-income countries because very few high-income countries are concerned with increasing spending on health.
We report potential total health spending per capita for low-income and middle-income countries by estimating the spending on health that would result if countries increased spending to the frontier level. Potential spending is greater than actual spending for most, but not all, countries, because the frontier level is above most countryspecific expected spending levels. The distance between a country's expected (forecasted) spending level and the frontier represents potential increases in health spending.
Finally, we used an additional set of frontiers to analyse three policy scenarios that could be used to increase government health spending in low-income and middleincome countries. In particular, we assessed how an increase in government spending and a reprioritisation of See Online for appendix government spending towards the health sector could separately and cumulatively increase government health spending. The first scenario supposed that governments are able to raise all-sector government spending, measured as a share of GDP, to reflect their highest spending peer. The second scenario supposed that governments are able to prioritise the health sector like their highest spending peers. And the third scenario supposed that governments are able to generate all-sector government spending in addition to prioritising the health sector like their highest spending peers. In each of these scenarios, the highest spending peers are identified using the frontier analysis. Precise specifications of these models are included in the appendix. Because it is more plausible that these gains could be made as a result of long-term policy changes, this analysis focused on the effect of health spending in 2040. All estimation and analysis was completed with Stata (version 13.1) and R (version 3.3.2) .
We report expected and potential spending estimates for each country, and for World Bank income groups and Global Burden of Disease super regions. Per capita and per GDP estimates reflect the entire group, meaning is the sum of spending divided by the sum of denominators World Bank income groups are four mutually exclusive categories assigned by the World Bank and based primarily on gross national income. Global burden of disease super regions are seven mutually exclusive categories based on geography and cause of death patterns.
Role of the funding source
The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. All authors had full access to the data in the study and JLD and CJLM had final responsibility for the decision to submit the manuscript. Table 1 In terms of growth rates, the middle-income countries are expected to grow much faster than low-income and high-income country groups. Upper-middle-income countries are expected to grow the fastest of the income groups at 5·3% (UI 4·1-6·8), whereas lower-middle income countries are expected to grow only a little slower at 4·2% (3·8-4·9). A slower growth rate is expected in low-income countries 1·8% (UI 1·0-2·8) and in highincome countries at 2·1% (1·8-2·4).
Results
The growth in per capita health spending shown in figure 2 will largely be driven by increases in government health spending. Globally, government health spending per capita will increase by $1126 (UI 697-1763) between 2014 and 2040. Gains will be largest in highincome countries. The next largest increase in government spending is estimated to be in southeast Asia, eastern Asia, and Oceania; additionally major increases in per capita government spending are expected in China and Maldives. Out-of-pocket and prepaid private health financing are also expected to grow, although less than growth in government spending. In low-income and middle-income countries, development assistance for health per capita is expected to increase by only $3·2 Table 2 shows that the share of health spending financed by governments is expected to increase as well. This increase is true at the global level and for all World Bank 2016 income groups and all global burden of disease super regions. Government spending as a share of the total is expected to increase the most in upper-middleincome countries, whereas the share of government spending is expected to increase by only a little, from 59·2% in 2014 to 65·3% (UI 58·7-72·3) in 2040, although total health spending is expected to increase substantially. Globally, the share of health spending that is financed through out-of-pocket payments is expected to decrease from 22·8% in 2014 to 21·4% (UI 16·5-26·2) in 2040. This proportion is expected to drop in 164 of 184 countries included in this study. Figure 3 shows the frontiers associated with potential total health spending, all-sector government spending, and government health spending. All three panels show an upward sloping frontier, meaning that more potential spending is associated with larger GDP per capita or allsector government spending. The gap between the frontier and individual countries suggests that many countries might be able to divert more resources to health. Table 3 (columns 2 and 3) provides country-specific estimates of the additional resources available if each low-income and middle-income country increased health spending to its predicted potential, as determined by GDP per capita and the frontier. The frontier analysis suggests that low-income countries as a whole could spend 64·3% (UI 13·0-115·1) more on health, across all sources, if all countries spent as much as their highest spending peers. Overall, lower-middle-income countries would spend 80·7% (UI 26·2-139·0) more and uppermiddle-income countries would spend 19·9% (0·0-94·0) more, if all countries spent at the level marked by the 
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Saint Vincent and the Grenadines frontier. Across regions, countries in sub-Saharan Africa would expand health spending the most, with an 82·8% (UI 35·7-121·1) increase, followed by south Asia (71·7%, 0·1-155·3) and north Africa and the Middle East (35·7%, 7·2-65·8). Figure 4 shows policy counterfactuals for the six most populous low-income and lower-middle-income countries and table 3 (columns 4 through 7) lists country-specific results. In this figure and table, the effects of three scenarios are shown: government spending increases (ie, increasing all-sector government spending to meet the frontier determined by GDP); reprioritisation of health in the government budget (ie, increasing government health spending to the frontier determined by all-sector government spending); and both government spending increases and reprioritisation of health in the government budget. In figure 4 , the vertical distance between the three counterfactuals and the starting position (in black) illustrates the potential gains. The magnitude of the increases resulting from the policy changes vary depending on the country context. For instance, in Bangladesh, Nigeria, and Philippines, increases in allsector government spending results in more government health spending rather than an increase in the share of the all-sector government budget that is devoted to health. By contrast, in India and Pakistan, increases in the share of the all-sector government budget that is devoted to health increases government health spending more than increases in all-sector government spending.
The implications of the policy changes for government health spending per capita vary across income groupings and region. For low-income countries, raising of government spending would increase government health spending per capita by $68 (UI 10-161), whereas reprioritisation of health would augment government health spending per capita by $107 (73-148). Government spending increases translate into $408 (UI per capita in lower-middle-income countries and $569 (0-4585) per capita in upper-middle-income countries. Reprioritisation of health would, by contrast, augment government health spending per capita by $525 (UI 349-697) in lower-middle-income countries and $3145 (761-5392) in upper-middle-income countries. Overall, in low-income and middle-income countries, more government health spending per capita is increased by reprioritisation of health in the government budget, rather than the raising of more government resources, although table 3 shows enormous country level variation. By contrast, sub-Saharan Africa stands out; increases in the amount of government spending to the frontier would lead to more health resources rather than an increase in the allocation of government spending on health. Figure 5 highlights the range of potential increases in government health spending as a proportion of GDP for low-income and middle-income countries. Countries with the highest potential increases are predominantly in Africa, the Middle East, and southeast Asia. 
Data in parentheses are uncertainty intervals. Data are percentages. GBD=global burden of disease. Figure 6 shows the difference between expected and potential government spending for each global burden of disease super region. The gain is shown in each region from the generation of more government spending and reprioritisation of the health sector, to the extent indicated by the frontier. In each region, these policy changes would lead to more government spending per capita on health and government health expenditure constituting a much higher share of total health expenditure. In per capita terms, southeast Asia, east Asia, and Oceania would increase government health spending per capita the most by reaching the potential levels. South Asia could potentially make the biggest increase in the share of total spending that is from the government.
Discussion
With GDP, all-sector government spending, and health spending forecast estimates as well as frontier analysis, we assessed alternative scenarios illustrating potential increase in funds for health. We find that future, expected health spending varies substantially across countries. However, increases in total and government health spending are expected for nearly all countries.
This study highlights the multifaceted role economic development has in the trajectory of health financing. Economic growth leads to more spending across sectors as well as on health. Our analysis emphasises that in most countries, and especially China, expected economic growth is likely to catalyse more health spending.
Although economic growth is clearly a major driver of health spending, it is not deterministic. We find that a great deal of variation remains for countries at similar levels of economic development. The USA and the United Arab Emirates, for instance, which are expected to have similar GDP per capita in 2040, spend very different amounts on health. The USA is expected to spend 18·5% (UI 16·5-20·7) of GDP on health by 2040, whereas the United Arab Emirates is estimated to spend just 4·6% (3·5-6·8) by that time. This finding is true at lower levels of income as well: Namibia expected to spend 10·2% (UI 8·4-13·2) of GDP on health in 2040, and India, estimated to spend 5·6% (4·6-7·3) of GDP on health in 2040, are expected to have similar GDP per capita in 2040. Overall, our 2040 health spending per capita estimates range from $42 to $15 026, and from 1·4% of GDP to 22·2%. Based on our potential spending estimates, most governments in low-income and middle-income countries could spend more on health in 2040 than in 2014 if they increased spending levels to reach the spending frontier, although the best strategy for increasing government spending depends on the country. In some countries, such as Bangladesh, Nigeria, and the Philippines, generation of more all-sector government spending would lead to the largest increase in government spending on health. For example, in 2014, government health spending per capita in Bangladesh was $21. In 2040, this figure is expected to be $81 . This amount is nonetheless below the $86 per capita estimated in 2012 purchasing power parity dollars to be a minimum required to provide universal primary health-care services. 38 However, we estimate that if the government could generate more allsector government spending at the frontier, as determined by their level of development, there would be an additional $254 (UI 32-710) available per capita to spend towards meeting health sector goals. Mechanisms for increasing government spending revolve often around tax policy and the enforcement of tax policy. In other countries, such as India and Pakistan, reprioritisation of government spending towards the health sector is key. In Pakistan, for instance, government spending on health per capita was $42 in 2014. Government spending per capita is expected to increase to $142 (UI 95-227) in 2040. With reprioritisation of government spending on health, an additional $267 (UI 82-558) could be spent per capita on health. Implementation of both policy options would naturally lead to more spending on health.
However, the ability to reach spending frontiers and realise potential spending is more within reach for some countries than others. Contextual features such as national debt, corruption, or a substantive portion of the economy being informal (meaning it is not taxed or monitored by the government) might be distinct challenges for some countries, and might make reaching the spending frontier difficult. Prospective, countryspecific, fiscal space analyses are needed to provide countries with tailored, country-specific capacity to spend assessments.
This study also shows that the differences in spending across countries, and across income groups in particular, are expected to persist. In some cases, in fact, we expect that without proactive policy changes, these differences will widen over time. Furthermore, our mean development assistance for health estimates suggest that development assistance for health will only marginally increase by 2040. The weak growth of health spending in the future in some countries is a result of the expected tepid growth in development assistance for health, and underlines the important part that development assistance for health continues to play in supporting health and health systems in low-income and middle-income countries.
14 An important factor related to this difference is how health spending is distributed within each country. We report per capita health spending in this paper, which excludes within-country inequalities. As health spending in most countries is unequal, and most of the world's poor now live in middle-income countries, understanding how development assistance for health can target those most in need will be increasingly important.
The Sustainable Development Goals (SDGs) include a subgoal on health financing that aims to "substantially increase health financing…especially in least developed countries and small island developing States." 39 Additionally, the Addis Ababa Action Agenda of 2015 has already made the case for increasing domestic funding for health by re-envisioning such commitments as investment cases and introducing innovative financing mechanisms, including private funding and external support. 40 In addition to planning for the SDGs, an understanding of future health spending is important in the context of the ongoing epidemiological transition occurring in many middle-income (and some low-income) countries. As countries' health burdens transition from infectious and childhood diseases to chronic, non-communicable diseases, different health system tools are needed. In some cases, these tools are expensive and require different health system infrastructure. As these health system demands are anticipated, health financing experts must develop plans rooted in medium-term and longterm forecasts, and consider a diverse set of policy options for raising the necessary resources.
An important point of caution is that this study does not assess the necessary amount of spending, and whether resources are spent efficiently and equitably. More spending does not necessarily guarantee better population health outcomes, and certainly does not secure more equitable distribution of health outcomes. Indeed, in most high-income countries, health policy spending targets revolve around the reduction of spending and strategies to increase efficiency. Health spending forecasts are valuable in high-income countries as a note of caution, because they reflect high levels of expected future spending based on past trends and relationships. However, our frontier analyses were designed to motivate governments and other development assistance partners to look at how countries compare, and to assess the strategies best suited to increase funding in low-income and middle-income countries. It is just as vital to understand how and where increased health spending is used, in addition to how it was mobilised. Improvement in the tracking of health resources is an important complement to our analysis of the future of global health financing. Estimation of future spending is inherently uncertain. Health spending is a complicated product of national, international, and subnational policy decision making, institutional factors, the supply and demand of the health system, economic development, and even war, civil strife, natural disaster, and other environmental issues potentially related to climate change. Many of these factors are not forecasted through 2040. To make credible health spending estimates through 2040, we rely on past global and country specific spending trends and the relationships between these variables and economic development, government spending, and demographic variables. Because these methods and forecasting in general are far from exact, we quantified uncertainty by propagating UIs that increased the further we projected into the future. These intervals propagate data, model, and parameter uncertainty, and should be interpreted as plausible ranges, as established by past trends and relationships. Although the mean projection marks our point estimate, the large UIs reflect space for policy change and potential changes in spending as determined by key policy and decision makers.
In addition to these UIs, four limitations to this research should be noted. First, the underlying retrospective data include measurement error and imputation. Precise data that are comparable across time and across countries, and are complete for a long time period and all countries, are not available. The measurement of out-of-pocket spending and prepaid private spending is particularly challenging in countries without precise expenditure tracking or where informal payments (under the table or black market) make up a major share of health spending. This research relies on the best data available, although it is not without its flaws. When forecasting, measurement error is likely to be exacerbated, which is why we prefer wide UIs that mark a great deal of variation.
Second, expected health spending for 2040 is based on past trends and relationships. These projections are based on empirical relationships that are observed between 1995 and 2014, across 184 countries. We model relationships associated with country trends, economic development, fiscal shocks, and the demographic transition, but cannot anticipate policy or environmental changes that have not been observed in our retrospective data. This research does not address novel policies that skirt observed historic norms, potential environmental changes and challenges, and technological innovations in excess of the innovations observed during the last 20 years.
Third, stochastic frontier analyses are just one method to implement peer country comparisons. Other methods such as data envelope analysis or simple calculations of the mean, median, and various percentiles in spending ratios, constitute other potential approaches. We chose stochastic frontier analysis because this technique allows for data measurement error and considers a broader range of peer countries on which to base the frontier. Additionally, we used a half-normal distribution of residual for our stochastic frontier. Alternatives for this assumption exist as well. Robustness analyses presented in the appendix show that although country-specific results vary, the primary conclusions of this analysis persist across these modelling choices.
Fourth, it is crucial to understand that the frontier analysis presented in this research is based exclusively on one input. The frontiers used to identify potential national health spending and potential all-sector government spending are based on expected GDP per capita, whereas the frontier used to identify potential government health spending is based on expected all-sector government spending. These are long-term counterfactuals and do not consider the short-run realities more thoroughly explored in fiscal space analyses. Issues related to debt, government capacity, structure of the economy, demand, health system efficiency, disease burden, and population age structure are also excluded from in this analysis.
In conclusion, variation in GDP and health spending is expected to persist through 2040. Past trends and relationships suggest that health spending levels will continue to diverge globally and even within income groups. Increases in spending to reflect potential levels, as determined by GDP per capita and peer nations, would lead to more resources for health. However, the pathways to ensure these increases vary from country to country. This analysis can inform decision makers about possible methods to mobilise funds for health, given their country's level of development and financing environment. Despite expected increases in spending, this spending in some places will probably be insufficient to meet complex health needs, underlining the ongoing role of development assistance for health in some countries. Insights into spending trajectories and financing gaps are crucial as health stakeholders face the ambitious SDG agenda and the push towards universal health coverage.
